Browse the detailed record of transactions filed by THOMAS PAUL, Director. Officer active across 3 companies, notably Surgalign Holdings, INC.. Cumulatively, 9 reports have been published. Total volume traded: €375k. The latest transaction was filed on 1 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Paul Thomas serves as a Director of Surgalign Holdings, Inc., Abiomed Inc., and Axogen, Inc. In this role, he participates in the governance of these companies and in making strategic decisions. His experience in the medical sector is valuable in guiding these companies towards innovation.